
Pacira BioSciences PCRX
€ 18.21
2.05%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Pacira BioSciences PEG 2011-2026 | PCRX
PEG Jährlich Pacira BioSciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.955 | 0.86 | -1.56 | -0.681 | -0.129 | 0.0624 | -35.8 | 6.95 | 0.0167 | 10.4 | -3.46 | 2.82 | -0.325 | -0.0435 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.4 | -35.8 | -1.56 |
PEG anderer Aktien in der Arzneimittelhersteller
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
-0.00952 | - | 7.5 % | $ 6.35 M | ||
|
Aerie Pharmaceuticals
AERI
|
0.33 | - | - | $ 754 M | ||
|
Alimera Sciences
ALIM
|
0.0306 | - | - | $ 142 M | ||
|
Agile Therapeutics
AGRX
|
-0.000002 | - | 10.11 % | $ 58.2 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.039 | - | 0.86 % | $ 117 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-0.649 | - | 0.12 % | $ 2.06 B | ||
|
Canopy Growth Corporation
CGC
|
1.99 M | - | -3.21 % | $ 114 M | ||
|
Cronos Group
CRON
|
0.469 | - | -1.32 % | $ 1.35 B | ||
|
Catalent
CTLT
|
0.248 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
-0.00968 | - | - | $ 50.1 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
1.63 | - | 1.17 % | $ 55 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
0.00578 | - | -0.1 % | $ 2.03 B | ||
|
Eagle Pharmaceuticals
EGRX
|
0.0227 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
0.00127 | - | - | $ 28.9 M | ||
|
HEXO Corp.
HEXO
|
-0.000621 | - | 2.45 % | $ 38.1 M | ||
|
Evoke Pharma
EVOK
|
-0.00288 | - | - | $ 36.6 M | ||
|
Emergent BioSolutions
EBS
|
-0.00041 | $ 11.07 | - | $ 567 M | ||
|
Athenex
ATNX
|
0.458 | - | -23.39 % | $ 1.76 M | ||
|
Jupiter Wellness
JUPW
|
-0.0108 | - | - | $ 33.6 M | ||
|
Evolus
EOLS
|
0.0272 | $ 4.35 | - | $ 270 M | ||
|
China Pharma Holdings
CPHI
|
0.00282 | - | -2.39 % | $ 11.4 M | ||
|
Harrow Health
HROW
|
0.514 | $ 49.44 | 3.63 % | $ 1.61 B | ||
|
OrganiGram Holdings
OGI
|
-0.00177 | $ 1.33 | - | $ 402 M | ||
|
Lannett Company
LCI
|
0.00126 | - | 1.15 % | $ 7.11 M | ||
|
Bausch Health Companies
BHC
|
0.917 | - | - | $ 2.22 B | ||
|
Sundial Growers
SNDL
|
0.0143 | $ 1.51 | 1.01 % | $ 3.37 M | ||
|
Neoleukin Therapeutics
NLTX
|
0.000058 | - | - | $ 193 M | ||
|
Perrigo Company plc
PRGO
|
2.67 | $ 14.49 | 0.59 % | $ 1.99 B | ||
|
Organogenesis Holdings
ORGO
|
-9.4 | - | -2.73 % | $ 492 M | ||
|
PetIQ
PETQ
|
0.000019 | - | 1.64 % | $ 400 M | ||
|
Aurora Cannabis
ACB
|
-0.0148 | - | -3.23 % | $ 86.3 M | ||
|
Tilray
TLRY
|
-0.0616 | $ 7.54 | - | $ 4.66 B | ||
|
ProPhase Labs
PRPH
|
-0.062 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
0.274 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
0.0825 | - | -4.76 % | $ 65.3 M | ||
|
Rockwell Medical
RMTI
|
-0.038 | $ 1.08 | -1.38 % | $ 25.2 M | ||
|
Relmada Therapeutics
RLMD
|
-0.0758 | - | - | $ 120 M | ||
|
OptiNose
OPTN
|
0.151 | - | - | $ 1.08 B | ||
|
cbdMD
YCBD
|
-0.00328 | $ 0.75 | -6.86 % | $ 3.23 M | ||
|
Assertio Holdings
ASRT
|
0.0017 | - | 2.31 % | $ 849 M | ||
|
PLx Pharma
PLXP
|
0.151 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
-0.00004 | - | - | $ 3.52 M | ||
|
Solid Biosciences
SLDB
|
-0.0148 | - | - | $ 261 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
0.0348 | - | - | $ 55.5 M | ||
|
SCYNEXIS
SCYX
|
-0.0203 | $ 0.81 | - | $ 38.8 M | ||
|
Veru
VERU
|
0.00214 | - | 3.03 % | $ 321 M | ||
|
Tricida
TCDA
|
0.0292 | - | - | $ 3.25 M | ||
|
TherapeuticsMD
TXMD
|
-0.01 | $ 2.32 | -2.52 % | $ 24.2 M | ||
|
Viatris
VTRS
|
-0.921 | - | - | $ 19.4 B |